| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.09 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |